HONG KONG, Jan. 28, 2026 (GLOBE NEWSWIRE) -- 707 Cayman Holdings Limited (“707 Cayman” or the “Company”) (Nasdaq: JEM), a Cayman Islands company that sells quality apparel products and provides supply chain management total solutions, has filed a registration statement on Form F-1 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (the “SEC”) relating to the potential offering and resale of up to 48,750,360 Class A Ordinary Shares (the “ELOC Shares”) issuable pursuant to an equi ...

Core Viewpoint - AGM Group Holdings Inc. has entered into a securities purchase agreement with an institutional investor, allowing the company to issue and sell ordinary shares for gross proceeds of up to US$25 million, establishing an equity line of credit facility [1][2]. Group 1: Securities Purchase Agreement - The ELOC Purchase Agreement grants the company the right to issue shares at its discretion, subject to customary conditions, including an effective resale registration statement [2]. - The purchase price for shares sold under the ELOC will be based on the market price during the applicable measurement period [2]. Group 2: Warrant Issuance and Capital Access - The company issued a five-year warrant to the investor for the purchase of 608,777 ordinary shares at an exercise price of $2.4639 per share [3]. - The ELOC provides flexible access to capital over a 24-month term, with proceeds intended for general corporate purposes, including working capital and project development [3]. Group 3: Company Overview - AGM Group Holdings Inc. is focused on ASIC chip design, high-performance computing server production, and the development of crypto mining equipment [4].

Registration No. 333-[ ] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 707 Cayman Holdings Limited (Exact name of Registrant as specified in its charter) Cayman Islands 5600 Not Applicable (State or Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to ...

Israel 2834 Not Applicable (Primary Standard Industrial Classification Code Number) As filed with the Securities and Exchange Commission on January 22, 2026 Registration No. 333-292528 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REDHILL BIOPHARMA LTD. (Exact name of Registrant as specified in its charter) Not Applicable (Translation of Registrant's name into English) (State or other jurisdiction o ...

Core Insights - Aptevo Therapeutics has entered into a $60 million equity line of credit (ELOC) agreement with Yorkville Advisors Global, LP, enhancing its financial flexibility and extending its funding runway into 2029 [1][2][3] Financial Flexibility - The ELOC allows Aptevo to raise funds incrementally at its discretion under market-based conditions, providing affordable capital financing with minimal fees and no warrants [2][3] - The combination of the ELOC and cash on hand is projected to fund the company for three years, allowing for the achievement of key clinical and preclinical milestones [1][3] Clinical Development - Aptevo's portfolio includes five CD3-engaging assets, with mipletamig being a first-in-class CD123 x CD3 bispecific currently evaluated in a Phase 1b/2 trial for frontline acute myeloid leukemia (AML) [5][7] - Mipletamig has shown high remission rates and a favorable safety profile in over 100 patients across three trials, with no observed cytokine release syndrome events [5][6] Pipeline and Innovation - The company is advancing a portfolio of tumor-directed CD3 programs, including bispecific candidates for prostate cancer and solid tumors, utilizing proprietary CRIS-7-derived CD3 binding domains [6][7] - Aptevo has two clinical candidates and six preclinical candidates targeting various solid tumors, all developed from its ADAPTIR and ADAPTIR-FLEX platforms [7]

Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 As filed with the Securities and Exchange Commission on December 31, 2025 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REDHILL BIOPHARMA LTD. (Exact name of Registrant as specified in its charter) Not Applicable (Translation of Registrant's name into English) (Address, including zip code, and telephone number, including area code, of Registrant's principal executive offices) RedHill Biopharma In ...

As filed with the U.S. Securities and Exchange Commission on November 25, 2025. Registration No. 333-290902 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO REGISTRATION STATEMENT ON FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PMGC HOLDINGS INC. (Exact name of registrant as specified in its charter) Nevada 5912 33-2382547 (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) (I.R. ...

Core Points - Aptera Motors Corp. has announced that its registration statement on Form S-1 related to its Equity Line of Credit (ELOC) has become effective, marking a significant milestone for the company [1][3] - The ELOC allows Aptera to sell up to $75 million of its Class B common stock to New Circle Principal Investments LLC, providing flexible access to capital to support operational and strategic goals [2][3] Company Overview - Aptera Motors Corp. is a solar mobility company focused on developing highly efficient vehicles, particularly a solar electric vehicle that utilizes advancements in aerodynamics, material science, and solar technology [6] - The company aims to create a sustainable business that positively impacts stakeholders and the environment, and is headquartered in Carlsbad, California [6] Financial Strategy - The proceeds from the ELOC are expected to support validation and production readiness, including tooling and other necessary activities to bring Aptera's Launch Edition vehicles to market [3] - The ELOC is designed to align funding with development and production timelines, allowing the company to access capital incrementally [3]

Core Viewpoint - Safe Harbor Financial has successfully regained compliance with Nasdaq listing requirements and has executed a recapitalization strategy that significantly improves its financial position and operational flexibility [1][2][3][6]. Financial Position - The company raised $6.8 million in new capital and eliminated $18.8 million of debt, resulting in a nearly debt-free status [2][6]. - A $150 million equity line of credit (ELOC) has been established, with potential expansion up to $500 million, aimed at funding lending to cannabis-related businesses (CRBs) and expanding its fintech platform [1][5]. Strategic Initiatives - The appointment of Terry Mendez as CEO in February 2025 has led to a focused strategy on regaining Nasdaq compliance, addressing liquidity challenges, and positioning for long-term success [3][6]. - The company has eliminated over $3 million in annualized costs and restructured its Board of Directors and Executive Management to align with a new strategic vision [3][6]. Operational Flexibility - The recapitalization provides substantial operational flexibility, allowing the company to pursue growth opportunities in cannabis banking and lending markets without immediate capital pressure [7]. - The ELOC will enable the company to make accretive deployments that are expected to generate returns exceeding the cost of capital, further strengthening its capital structure [5][7]. Industry Context - Safe Harbor is a leader in providing financial services tailored to the cannabis industry, having facilitated over $26 billion in cannabis-related transactions across 41 states and territories [8].

Core Insights - American Picture House Corporation has entered into a $100 million Equity Line of Credit (ELOC) Agreement with RH2 Equity Partners, which will provide the company with flexible access to capital over a 24-month period [1][2][3] - The proceeds from the ELOC can be utilized for general corporate purposes, including working capital, project development, and production financing [2] - The CEO of American Picture House emphasized that this financing agreement will allow the company to expand its film slate and pursue high-quality content opportunities while preparing for a planned uplisting to a national exchange [3] Company Overview - American Picture House Corporation is an independent film finance and production company focused on producing, acquiring, and distributing high-quality feature films and related media content [4] - The company aims to leverage its industry relationships and financial structuring expertise to build a diverse slate of projects for global audiences [4] Investor Overview - RH2 Equity Partners is a strategic investment firm that specializes in structured financing solutions for emerging public companies [5] - The firm provides tailored capital structures, including ELOCs, and offers support for compliance and corporate governance [5]